Cargando…

DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2

Metastasis is a major cause of colorectal cancer (CRC) mortality, but its molecular mechanisms are still not fully understood. Here, we show that upregulated DDX39B correlates with liver metastases and aggressive phenotypes in CRC. DDX39B is an independent prognostic factor associated with poor clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Gang, Yuan, Hang, Li, Qin, Zhang, Jie, Guo, Yafei, Feng, Tianyu, Gu, Rui, Ou, Deqiong, Li, Siqi, Li, Kai, Lin, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381590/ https://www.ncbi.nlm.nih.gov/pubmed/35973989 http://dx.doi.org/10.1038/s41392-022-01096-7

Ejemplares similares

DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer
por: Zhao, Gang, et al.
Publicado: (2023)

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53
por: Guo, Yafei, et al.
Publicado: (2021)

JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression
por: Lei, Hu, et al.
Publicado: (2022)

COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization
por: Zhang, Mingzhi, et al.
Publicado: (2019)

The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts
por: Gu, Junjie, et al.
Publicado: (2021)

DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1
por: Zhang, Haonan, et al.
Publicado: (2022)

ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
por: Yang, Weiwei, et al.
Publicado: (2012)

Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation
por: Chen, Tsan-Jan, et al.
Publicado: (2019)

The DDX39B/FUT3/TGFβR-I axis promotes tumor metastasis and EMT in colorectal cancer
por: He, Chengcheng, et al.
Publicado: (2021)

The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export
por: Saleem, Irfana, et al.
Publicado: (2021)

Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer
por: Li, Qiong, et al.
Publicado: (2015)

MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation
por: Wu, Yang, et al.
Publicado: (2022)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
por: Heerma van Voss, Marise R, et al.
Publicado: (2017)

Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma
por: Xia, Qing, et al.
Publicado: (2021)

TGF-βRII regulates glucose metabolism in oral cancer-associated fibroblasts via promoting PKM2 nuclear translocation
por: Wu, Fanglong, et al.
Publicado: (2022)

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
por: Zhang, Tong, et al.
Publicado: (2018)

miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis
por: Cheng, Chao, et al.
Publicado: (2021)

PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
por: Li, Tian-En, et al.
Publicado: (2020)

Nuclear translocation of beta-catenin in colorectal cancer
por: Kobayashi, M, et al.
Publicado: (2000)

RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma
por: Tu, Qiu, et al.
Publicado: (2022)

Structural basis for high-order complex of SARNP and DDX39B to facilitate mRNP assembly
por: Xie, Yihu, et al.
Publicado: (2023)

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
por: Fu, Dechen, et al.
Publicado: (2022)

Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress
por: Qi, Hailong, et al.
Publicado: (2019)

Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation
por: Zhao, Fan, et al.
Publicado: (2020)

HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma
por: Zhang, Ruixue, et al.
Publicado: (2020)

Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2
por: Liang, Ji, et al.
Publicado: (2017)

The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate
por: Hirano, Minato, et al.
Publicado: (2023)

PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016)

PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2022)

Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability
por: Wu, Haili, et al.
Publicado: (2016)

DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy
por: Szymura, Szymon J., et al.
Publicado: (2020)

RNF39 mediates K48-linked ubiquitination of DDX3X and inhibits RLR-dependent antiviral immunity
por: Wang, Wenwen, et al.
Publicado: (2021)

Oxymatrine Inhibits Colorectal Cancer Metastasis via Attenuating PKM2-Mediated Aerobic Glycolysis
por: Li, Xiaoping, et al.
Publicado: (2020)

Rab25 acts as an oncogene and participates in the regulation of aerobic glycolysis via PKM2 in gastric adenocarcinoma
por: Zheng, Tianyu, et al.
Publicado: (2021)

DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway
por: Shen, Lin, et al.
Publicado: (2022)

Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2020)

Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer
por: Yan, Shi-Hai, et al.
Publicado: (2022)

HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma
por: Huang, Jiajun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcmi7bm3kqnjm6qs259lejqr85